Procter & Gamble vs AB InBev
Procter and Gamble dominates household and personal care with billion-dollar brands that command shelf space and pricing power across global retail, while AB InBev brews and sells beer under a portfolio of global and local brands including Budweiser and Corona, relying on volume and premiumization to drive revenue. Both consumer goods giants compete in mature categories where brand equity, distribution reach, and marketing spend determine who wins share. Procter and Gamble vs AB InBev weighs organic growth rates, margin expansion, and how each company's pricing strategy holds up against private-label competition and consumer trade-down pressure.
Procter and Gamble dominates household and personal care with billion-dollar brands that command shelf space and pricing power across global retail, while AB InBev brews and sells beer under a portfol...
Why It's Moving
Analyst Consensus Tilts Bullish on Procter & Gamble as Recent Updates Push Price Targets Higher
- Analyst consensus shows 10 Buy and 10 Hold ratings with an average price target of $160-$172, indicating moderate conviction rather than overwhelming enthusiasm for the stock
- Recent updates from major firms like Piper Sandler and JP Morgan (through mid-April) reflect confidence in P&G's ability to recover market share through product innovations including Tide evo and Olay relaunches
- The wide price target range ($142-$186) underscores split sentiment on whether P&G can stabilize U.S. consumer demand or faces deeper market softness, with Q3 earnings data serving as the key near-term catalyst
Analysts Rally Behind BUD with Moderate Buy Consensus Signaling Growth Potential.
- Brokerages lean bullish with 11 Buy ratings, 4 Holds, and 1 Strong Buy, highlighting BUD's attractive valuation at a P/E of 20.79 versus peers.
- Goldman Sachs ramped up its position by 265,783 shares to over 1.3 million worth $81M, underscoring institutional confidence in BUD's market position.
- Strategic acquisition of BeatBox targets Gen Z drinkers, bolstering BUD's push into innovative beverages amid shifting consumer tastes.
Analyst Consensus Tilts Bullish on Procter & Gamble as Recent Updates Push Price Targets Higher
- Analyst consensus shows 10 Buy and 10 Hold ratings with an average price target of $160-$172, indicating moderate conviction rather than overwhelming enthusiasm for the stock
- Recent updates from major firms like Piper Sandler and JP Morgan (through mid-April) reflect confidence in P&G's ability to recover market share through product innovations including Tide evo and Olay relaunches
- The wide price target range ($142-$186) underscores split sentiment on whether P&G can stabilize U.S. consumer demand or faces deeper market softness, with Q3 earnings data serving as the key near-term catalyst
Analysts Rally Behind BUD with Moderate Buy Consensus Signaling Growth Potential.
- Brokerages lean bullish with 11 Buy ratings, 4 Holds, and 1 Strong Buy, highlighting BUD's attractive valuation at a P/E of 20.79 versus peers.
- Goldman Sachs ramped up its position by 265,783 shares to over 1.3 million worth $81M, underscoring institutional confidence in BUD's market position.
- Strategic acquisition of BeatBox targets Gen Z drinkers, bolstering BUD's push into innovative beverages amid shifting consumer tastes.
Investment Analysis
Pros
- Procter & Gamble delivered stable fiscal 2025 results with a 2% organic sales growth and an 8% increase in diluted EPS despite a volatile environment.
- The company expects to continue organic sales growth, EPS growth, and strong free cash flow productivity in fiscal 2026.
- Analyst consensus strongly favours the stock with an average price target around $174, implying about 19% upside from current levels.
Considerations
- Net sales were flat year-over-year in fiscal 2025, indicating challenges in top-line growth.
- Recent insider selling and some lowered price targets suggest cautious sentiment among company insiders and analysts.
- The company's price-to-earnings ratio is relatively high, raising concerns about potential overvaluation.
AB InBev
BUD
Pros
- Anheuser-Busch InBev is the largest global player in alcoholic and non-alcoholic beverage manufacturing and distribution, providing scale advantages.
- The company maintains a significant market capitalization, indicating strong investor backing and liquidity.
- Its extensive brand portfolio and global footprint support diversified revenue streams and resilience against regional downturns.
Considerations
- The alcoholic beverage sector faces regulatory risks and changing consumer preferences that may impact growth.
- Anheuser-Busch InBev is exposed to macroeconomic pressures including inflation and currency fluctuations affecting profitability.
- The company's ADR share price shows limited short-term upside, with relatively modest recent price appreciation.
Procter & Gamble (PG) Next Earnings Date
Procter & Gamble's next earnings release is expected on July 29, 2026, which will cover the fourth quarter of fiscal year 2026. This timing aligns with the company's historical quarterly earnings announcement schedule, typically occurring late in the month following the end of each fiscal quarter. Investors should anticipate the company will report results for the period ending June 30, 2026, along with any updates to full-year guidance at that time.
AB InBev (BUD) Next Earnings Date
Anheuser-Busch InBev (BUD) is expected to report its next earnings on May 5-7, 2026, ahead of market open, covering the first quarter of 2026. This date aligns with projections from recent analyst calendars following the prior Q4 2025 release on February 12, 2026. The company has not yet officially confirmed the exact timing, consistent with its historical quarterly pattern.
Procter & Gamble (PG) Next Earnings Date
Procter & Gamble's next earnings release is expected on July 29, 2026, which will cover the fourth quarter of fiscal year 2026. This timing aligns with the company's historical quarterly earnings announcement schedule, typically occurring late in the month following the end of each fiscal quarter. Investors should anticipate the company will report results for the period ending June 30, 2026, along with any updates to full-year guidance at that time.
AB InBev (BUD) Next Earnings Date
Anheuser-Busch InBev (BUD) is expected to report its next earnings on May 5-7, 2026, ahead of market open, covering the first quarter of 2026. This date aligns with projections from recent analyst calendars following the prior Q4 2025 release on February 12, 2026. The company has not yet officially confirmed the exact timing, consistent with its historical quarterly pattern.
Buy PG or BUD in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
